Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-4-10
pubmed:abstractText
Torasemide is frequently used for the treatment of hypertension and heart failure. However, the determinants of torasemide pharmacokinetics in patients during steady-state conditions are largely unknown. We therefore explored the impact of genetic polymorphisms of cytochrome P450 (CYP) 2C9 (CYP2C9) and organic anion transporting polypeptide (OATP) 1B1 (SLCO1B1), gender, and the effects of losartan and irbesartan comedication on the interindividual variability of steady-state pharmacokinetics of torasemide.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0312-5963
pubmed:author
pubmed:issnType
Print
pubmed:volume
47
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
323-32
pubmed:meshHeading
pubmed-meshheading:18399713-Aged, pubmed-meshheading:18399713-Analysis of Variance, pubmed-meshheading:18399713-Angiotensin II Type 1 Receptor Blockers, pubmed-meshheading:18399713-Antihypertensive Agents, pubmed-meshheading:18399713-Area Under Curve, pubmed-meshheading:18399713-Aryl Hydrocarbon Hydroxylases, pubmed-meshheading:18399713-Calibration, pubmed-meshheading:18399713-Chromatography, High Pressure Liquid, pubmed-meshheading:18399713-Dose-Response Relationship, Drug, pubmed-meshheading:18399713-Drug Interactions, pubmed-meshheading:18399713-Female, pubmed-meshheading:18399713-Genotype, pubmed-meshheading:18399713-Half-Life, pubmed-meshheading:18399713-Humans, pubmed-meshheading:18399713-Male, pubmed-meshheading:18399713-Organic Anion Transporters, pubmed-meshheading:18399713-Pharmacogenetics, pubmed-meshheading:18399713-Sex Characteristics, pubmed-meshheading:18399713-Sulfonamides
pubmed:year
2008
pubmed:articleTitle
Determinants of steady-state torasemide pharmacokinetics: impact of pharmacogenetic factors, gender and angiotensin II receptor blockers.
pubmed:affiliation
Department of Cardiology, Helios-Hospital Schwerin, Schwerin, Germany. dierk.werner@arcor.de
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't